Andrew Lo, 10% Owner at Urovant Sciences Ltd. (UROV), bought 7,500 shares at $8.30 ($62K) on 2019-06-12, disclosed to the SEC on 2019-06-14.
Open-market purchase of $62k UROV by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| BBIO | BUY | 2022-01-03 | $99K | — | Filing → |
| UROV | BUY | 2019-06-19 | $303K | — | Filing → |
| UROV | BUY | 2019-06-19 | $56K | — | Filing → |